September 2003

Validation of Pretrial ELIspot Measurements logo in a gray background | Validation of Pretrial ELIspot Measurements
Assays
Validation of Pretrial ELIspot MeasurementsValidation of Pretrial ELIspot Measurements
Validation of Pretrial ELIspot Measurements
Sep 1, 2003
byBPI Contributor
Unwanted Immunogenicity of Therapeutic Biological Products logo in a gray background | Unwanted Immunogenicity of Therapeutic Biological Products
Pre-Clinical & Clinical Trials
Unwanted Immunogenicity of Therapeutic Biological ProductsUnwanted Immunogenicity of Therapeutic Biological Products
Unwanted Immunogenicity of Therapeutic Biological Products
Sep 1, 2003
byBPI Contributor
Possible Regulatory Changes logo in a gray background | Possible Regulatory Changes
Regulatory Affairs
Possible Regulatory ChangesPossible Regulatory Changes
Possible Regulatory Changes
Sep 1, 2003
byBPI Contributor
Science in Translation logo in a gray background | Science in Translation
Economics
Science in TranslationScience in Translation
Science in Translation
Sep 1, 2003
byBPI Contributor
Products, Services, and Literature logo in a gray background | Products, Services, and Literature
Business
Products, Services, and Literature September 2003Products, Services, and Literature September 2003
Products, Services, and Literature
Sep 1, 2003
byBPI Contributor
Euro TIDES 2003 logo in a gray background | Euro TIDES 2003
Business
Euro TIDES 2003Euro TIDES 2003
Euro TIDES 2003
Sep 1, 2003
byBPI Contributor
Drug Pricing Principles logo in a gray background | Drug Pricing Principles
Economics
Drug Pricing PrinciplesDrug Pricing Principles
Drug Pricing Principles
Sep 1, 2003
byBPI Contributor
Conferences, Courses, and Events logo in a gray background | Conferences, Courses, and Events
Business
Conferences, Courses, and EventsConferences, Courses, and Events
Conferences, Courses, and Events
Sep 1, 2003
byBPI Contributor
Computer Validation Basics logo in a gray background | Computer Validation Basics
Information Technology
Computer Validation BasicsComputer Validation Basics
Computer Validation Basics
Sep 1, 2003
byBPI Contributor
Characterization of Alternatives to Animal-Derived Raw Materials logo in a gray background | Characterization of Alternatives to Animal-Derived Raw Materials
Biochemicals/Raw Materials
Characterization of Alternatives to Animal-Derived Raw MaterialsCharacterization of Alternatives to Animal-Derived Raw Materials
Characterization of Alternatives to Animal-Derived Raw Materials
Sep 1, 2003
byBPI Contributor
Characteristics of a Good Antibody Manufacturing Process logo in a gray background | Characteristics of a Good Antibody Manufacturing Process
MAb
Characteristics of a Good Antibody Manufacturing ProcessCharacteristics of a Good Antibody Manufacturing Process
Characteristics of a Good Antibody Manufacturing Process
Sep 1, 2003
byBPI Contributor
Bringing Together Software Audit Data for Regulatory Compliance logo in a gray background | Bringing Together Software Audit Data for Regulatory Compliance
Information Technology
Bringing Together Software Audit Data for Regulatory ComplianceBringing Together Software Audit Data for Regulatory Compliance
Bringing Together Software Audit Data for Regulatory Compliance
Sep 1, 2003
byBPI Contributor
An Overview of the Japanese Biotechnology Industry logo in a gray background | An Overview of the Japanese Biotechnology Industry
Bioregions
An Overview of the Japanese Biotechnology IndustryAn Overview of the Japanese Biotechnology Industry
An Overview of the Japanese Biotechnology Industry
Sep 1, 2003
byBPI Contributor

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Ask the Expert webcasts
ATE Webcasts
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Ask the Expert webcasts
ATE Webcasts
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Emerson white paper
Sponsored Content
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency

Nov 12, 2024

WuXi Bio white paper
Sponsored Content
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products

Nov 8, 2024

Bora white paper
Sponsored Content
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages

Nov 8, 2024